Kevin Buehler insider trades

Open-market stock purchases and sales by Kevin Buehler, Director at Precision Biosciences Inc, from SEC Form 4 filings since Nov 8, 2019.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +43%.

Recent trades

DateStockTradeValue
Jun 3, 2026DTIL Precision Biosciences IncBought (not open market)—
May 20, 2026DTIL Precision Biosciences IncBought (not open market)—

Companies traded

  • DTIL Precision Biosciences Inc: 3 buys, last Jun 3, 2026

Get free alerts when Kevin Buehler files a new trade →